UNIVERSITY OF ALABAMA AT BIRMINGHAM
Novel Retinal Biomarker Development in Early Alzheimer's Disease
Novel Retinal Biomarker Development in Early Alzheimer's Disease is a funding opportunity from UNIVERSITY OF ALABAMA AT BIRMINGHAM, up to 405955, closing May 31, 2027.
May 31, 2027
(304d left)Overview
1 Alzheimer’s disease (AD) is a progressive neurodegenerative disease affecting approximately 6.7 million 2 Americans aged 65 and older and projected to reach 13.8 million by 2060. Progress in the management and 3 treatment of AD is limited by lack of early diagnostics, which are critical to the development of…